$0.15 EPS Expected for Zayo Group Holdings, Inc. (ZAYO); Spark Investment Management Trimmed By $330,000 Its Chemocentryx (CCXI) Stake – The DMinute

Zayo Group Holdings, Inc. (NYSE:ZAYO) Logo

Spark Investment Management Llc decreased Chemocentryx Inc (CCXI) stake by 16.78% reported in 2018Q3 SEC filing. Spark Investment Management Llc sold 27,500 shares as Chemocentryx Inc (CCXI)’s stock declined 9.75%. The Spark Investment Management Llc holds 136,400 shares with $1.72 million value, down from 163,900 last quarter. Chemocentryx Inc now has $553.26M valuation. The stock increased 0.37% or $0.04 during the last trading session, reaching $10.95. About 124,477 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 69.59% since January 2, 2018 and is uptrending. It has outperformed by 69.59% the S&P500. Some Historical CCXI News: 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/05/2018 – ChemoCentryx 1Q Loss/Shr 19c; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En

Analysts expect Zayo Group Holdings, Inc. (NYSE:ZAYO) to report $0.15 EPS on February, 6.They anticipate $0.08 EPS change or 34.78% from last quarter’s $0.23 EPS. ZAYO’s profit would be $35.49 million giving it 37.87 P/E if the $0.15 EPS is correct. After having $0.09 EPS previously, Zayo Group Holdings, Inc.’s analysts see 66.67% EPS growth. The stock decreased 0.53% or $0.12 during the last trading session, reaching $22.72. About 1.70 million shares traded. Zayo Group Holdings, Inc. (NYSE:ZAYO) has declined 27.11% since January 2, 2018 and is downtrending. It has underperformed by 27.11% the S&P500. Some Historical ZAYO News: 26/03/2018 – lnterdata Selects Zayo for Dark Fiber; 06/04/2018 – Zayo Acquires Data Center In McLean, Virginia; 03/05/2018 – Zayo To Advance Evaluation of REIT Conversion; 05/04/2018 – Babson Names President and CEO of UNICEF USA, Caryl M. Stern, and Co-Founder and CEO of Endeavor, Linda Rottenberg, as 2018 Commencement Speakers; 03/05/2018 – ZAYO: RESIGNATION OF COO; 18/04/2018 – Zayo Closes Acquisition Of Neutral Path; 15/05/2018 – Blue Harbour Adds Fortinet, Exits Zayo Group: 13F; 16/04/2018 – ZAYO GROUP HOLDINGS INC – WILL EXPAND ITS EUROPEAN DATA CENTER PRESENCE WITH A NEW LOCATION IN FELTHAM, UK; 03/05/2018 – Zayo Group Closes Below 200-Day Moving Average: Technicals; 02/04/2018 – Wireless Carrier Selects Zayo for Significant National Expansion

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Seekingalpha.com which released: “ChemoCentryx terminates previously announced common stock offering – Seeking Alpha” on September 28, 2018, also Globenewswire.com with their article: “ChemoCentryx Announces Proposed Public Offering of Common Stock – GlobeNewswire” published on September 26, 2018, Seekingalpha.com published: “ChemoCentryx launches $75M stock offering – Seeking Alpha” on September 26, 2018. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Globenewswire.com and their article: “ChemoCentryx Reports Third Quarter 2018 Financial Results and Recent Highlights – GlobeNewswire” published on November 08, 2018 as well as Seekingalpha.com‘s news article titled: “ChemoCentryx: Discounted, Underfollowed, And Misunderstood Biotech – Seeking Alpha” with publication date: May 07, 2018.

Analysts await ChemoCentryx, Inc. (NASDAQ:CCXI) to report earnings on March, 8. They expect $-0.27 EPS, down 133.75% or $1.07 from last year’s $0.8 per share. After $-0.22 actual EPS reported by ChemoCentryx, Inc. for the previous quarter, Wall Street now forecasts 22.73% negative EPS growth.

Since October 16, 2018, it had 0 buys, and 3 insider sales for $86.26 million activity. Cappel Markus J. also sold $332,779 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) shares. $86,554 worth of stock was sold by Schall Thomas J. on Wednesday, November 7. $85.85 million worth of ChemoCentryx, Inc. (NASDAQ:CCXI) was sold by GLAXOSMITHKLINE PLC.

Among 3 analysts covering ChemoCentryx (NASDAQ:CCXI), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. ChemoCentryx had 3 analyst reports since August 14, 2018 according to SRatingsIntel. The stock has “Buy” rating by Canaccord Genuity on Monday, November 12. The firm earned “Neutral” rating on Tuesday, August 14 by JP Morgan.

Spark Investment Management Llc increased Transglobe Energy Corp (NASDAQ:TGA) stake by 154,000 shares to 292,000 valued at $974,000 in 2018Q3. It also upped J Jill Inc stake by 86,800 shares and now owns 419,200 shares. Nic Inc (NASDAQ:EGOV) was raised too.

Investors sentiment decreased to 0.98 in 2018 Q3. Its down 0.61, from 1.59 in 2018Q2. It fall, as 14 investors sold CCXI shares while 29 reduced holdings. 13 funds opened positions while 29 raised stakes. 26.80 million shares or 1.64% more from 26.37 million shares in 2018Q2 were reported. Deutsche Financial Bank Ag invested in 0% or 98,188 shares. D E Shaw Communications accumulated 0% or 259,837 shares. Panagora Asset Mngmt holds 0.02% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 324,114 shares. Ameriprise Inc invested in 0% or 134,387 shares. Amer Century Companies reported 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Adams Diversified Equity Fund has 0.03% invested in ChemoCentryx, Inc. (NASDAQ:CCXI). Bvf Inc Il holds 7.52% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 6.77M shares. Dorsey Wright Assocs accumulated 975 shares. Schwab Charles Invest Inc accumulated 49,177 shares. Aqr Limited Liability Com owns 22,364 shares for 0% of their portfolio. Invesco Limited holds 0% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 136,127 shares. Spark Invest Mgmt Ltd Com holds 0.1% or 136,400 shares in its portfolio. Cadence Ltd has 95,344 shares for 0.07% of their portfolio. Ny State Common Retirement Fund reported 25,400 shares. Gsa Cap Llp reported 0.12% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI).

Zayo Group Holdings, Inc., through its subsidiaries, provides bandwidth infrastructure solutions for the communications industry in the United States, Canada, and Europe. The company has market cap of $5.38 billion. The firm operates in six divisions: Fiber Solutions, Transport, Enterprise Networks, Zayo Colocation , Allstream, and Other. It has a 55.82 P/E ratio. The Fiber Solutions segment provides dark fiber, and fiber-to-the-tower and small cell mobile infrastructure services for carriers and other communication service providers, Internet service providers, wireless service providers, media and content companies, large enterprises, and other companies.

Among 7 analysts covering Zayo Group Holdings (NYSE:ZAYO), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Zayo Group Holdings had 7 analyst reports since September 4, 2018 according to SRatingsIntel. JP Morgan upgraded the stock to “Overweight” rating in Wednesday, November 28 report. The rating was maintained by Raymond James with “Outperform” on Thursday, November 8. The stock has “Neutral” rating by UBS on Thursday, November 8. The rating was maintained by Deutsche Bank on Wednesday, November 14 with “Buy”. As per Wednesday, November 28, the company rating was upgraded by J.P. Morgan. As per Thursday, November 8, the company rating was downgraded by BTIG Research.

Since July 9, 2018, it had 0 insider purchases, and 10 selling transactions for $20.67 million activity. 1,935 shares were sold by Steinfort Matt, worth $65,809 on Thursday, October 4. 2,500 shares were sold by Connor Richard W., worth $96,250. $10.00 million worth of stock was sold by Caruso Daniel on Tuesday, October 30. $80,162 worth of stock was sold by Waters John F Jr. on Wednesday, October 3. Rottenberg Linda sold $195,000 worth of stock. The insider Mays Sandra sold $54,152.

Investors sentiment increased to 1.97 in Q3 2018. Its up 0.25, from 1.72 in 2018Q2. It increased, as 20 investors sold Zayo Group Holdings, Inc. shares while 70 reduced holdings. 53 funds opened positions while 124 raised stakes. 216.91 million shares or 1.66% less from 220.58 million shares in 2018Q2 were reported. Sumitomo Mitsui Tru Holdg, a Japan-based fund reported 664,774 shares. Art Advsrs Ltd Company holds 0.13% or 81,200 shares. Invesco Limited invested in 0.01% or 1.08 million shares. Commonwealth Fincl Bank Of has invested 0% in Zayo Group Holdings, Inc. (NYSE:ZAYO). Quantbot Technologies Limited Partnership holds 101,958 shares. Cbre Clarion Ltd Llc has 0.01% invested in Zayo Group Holdings, Inc. (NYSE:ZAYO) for 30,879 shares. Nomura owns 9,820 shares for 0% of their portfolio. Jefferies Llc reported 0.02% of its portfolio in Zayo Group Holdings, Inc. (NYSE:ZAYO). Blackrock accumulated 14.86M shares. Magnetar Financial Limited Liability Company owns 11,578 shares for 0.01% of their portfolio. Renaissance Techs Limited Liability Co has 943,200 shares. 46,143 are owned by Aperio Ltd Com. Cubist Systematic Strategies Limited Liability Co has 0.12% invested in Zayo Group Holdings, Inc. (NYSE:ZAYO) for 61,321 shares. 104,260 are held by Castleark Mngmt Ltd Liability. Ckw Financial stated it has 1,100 shares or 0.01% of all its holdings.

Another recent and important Zayo Group Holdings, Inc. (NYSE:ZAYO) news was published by Businesswire.com which published an article titled: “Zayo to Expand East Coast Data Center Presence – Business Wire” on December 17, 2018.

Zayo Group Holdings, Inc. (NYSE:ZAYO) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *